Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
Go back to Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 81.82 -0.18 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.00 | 52 Week High | $8.22 | |||
| Open | $80.00 | 52 Week Low | $3.07 | |||
| Day High | $82.53 | P/E | N/A | |||
| Day Low | $79.69 | EPS | $-1.30 | |||
| Volume | 383,999 | |||||
